MiR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5

FEBS Letters

Volumn 585, Issue 8, 2011, Pages 1191-1196

  Miko, Edit ^a   Margitai, Zoltán ^b   Czimmerer, Zsolt ^a   Várkonyi, Ildikó ^b   Dezs, Balázs ^b   Lányi, Árpád ^b   Bacsó, Zsolt ^b   Scholtz, Beáta ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UDMHSC   (Hungary)

Author keywords

G1 delay; miR 126; SLC7A5; Small cell lung cancer

Indexed keywords

MICRORNA; MICRORNA 126; ONCOPROTEIN; PM 12841; PROTEIN SLC7A5; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; LUNG NEOPLASMS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SMALL CELL LUNG CARCINOMA; TIME FACTORS; TISSUE ARRAY ANALYSIS;

EID: 79954432422     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.03.039     Document Type: Article

References (26)

1. C. Guo, J.F. Sah, L. Beard, J.K. Willson, S.D. Markowitz, and K. Guda The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers Genes Chromosom. Cancer 47 2008 939 946
2. X.-C. Wang Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer Lung Cancer 72 2011 92 99
3. Zhong, M., Ma, X., Sun, C. and Chen, L. (2010) MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer. Chem. Biol. Interact. 184, 431-438.
4. J. Zhang, Y.Y. Du, Y.F. Lin, Y.T. Chen, L. Yang, H.J. Wang, and D. Ma The cell growth suppressor, mir-126, targets IRS-1 Biochem. Biophys. Res. Commun. 377 2008 136 140
5. J.E. Fish MiR-126 regulates angiogenic signaling and vascular integrity Dev. Cell 15 2008 272 284
6. S. Wang The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis Dev. Cell 15 2008 261 271
7. Barshack, I. et al. (2010) MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol. Res. Pract. 206, 578-584.
8. Feng, R. et al. (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 298, 50-63.
9. X. Li, Y. Shen, H. Ichikawa, T. Antes, and G.S. Goldberg Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration Oncogene 28 2009 4272 4283
10. E. Miko, Z. Czimmerer, E. Csanky, G. Boros, J. Buslig, B. Dezso, and B. Scholtz Differentially expressed microRNAs in small cell lung cancer Exp. Lung Res. 35 2009 646 664
11. K. Kaira Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung Pathol. Res. Pract. 204 2008 553 561
12. Oglesby, I.K., Bray, I.M., Chotirmall, S.H., Stallings, R.L., O'Neill, S.J., McElvaney, N.G. and Greene, C.M. (2010) miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J. Immunol. 184, 1702-1709.
13. Z. Li Distinct microRNA expression profiles in acute myeloid leukemia with common translocations Proc. Natl. Acad. Sci. USA 105 2008 15535 15540
14. K. Kaira CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases Ann. Surg. Oncol. 16 2009 3473 3481
15. K. Nakanishi Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract Virchows Arch. 451 2007 681 690 (Pubitemid 47340986)
16. T. Sakata L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer Pathol. Int. 59 2009 7 18
17. Fan, X., Ross, D.D., Arakawa, H., Ganapathy, V., Tamai, I. and Nakanishi, T. (2010) Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Biochem. Pharmacol. 80, 811-818.
18. H. Nawashiro L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors Int. J. Cancer 119 2006 484 492 (Pubitemid 43955699)
19. D.B. Shennan, and J. Thomson Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells Oncol. Rep. 20 2008 885 889
20. P. Nicklin Bidirectional transport of amino acids regulates mTOR and autophagy Cell 136 2009 521 534
21. A.L. Edinger, and C.B. Thompson Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake Mol. Biol. Cell 13 2002 2276 2288 (Pubitemid 34831333)
22. X.M. Liu, S.V. Reyna, D. Ensenat, K.J. Peyton, H. Wang, A.I. Schafer, and W. Durante Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth FASEB J. 18 2004 768 770
23. F.H. Blackhall, M. Pintilie, M. Michael, N. Leighl, R. Feld, M.S. Tsao, and F.A. Shepherd Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer Clin. Cancer Res. 9 2003 2241 2247 (Pubitemid 36687649)
24. S.M. Moore, R.C. Rintoul, T.R. Walker, E.R. Chilvers, C. Haslett, and T. Sethi The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway Cancer Res. 58 1998 5239 5247 (Pubitemid 28521188)
25. O.E. Pardo, A. Arcaro, G. Salerno, T.D. Tetley, T. Valovka, I. Gout, and M.J. Seckl Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells Oncogene 20 2001 7658 7667 (Pubitemid 33111865)
26. G. Razzini, C.P. Berrie, S. Vignati, M. Broggini, G. Mascetta, A. Brancaccio, and M. Falasca Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines FASEB J. 14 2000 1179 1187 (Pubitemid 30350400)